Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Carl Djerassi
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Career== In 1942/43, Djerassi worked for [[Chemical Industry Basel|CIBA]] in [[New Jersey]], developing [[Pyribenzamine]]<ref name=CHFOralHistory/> (tripelennamine), his first patent and one of the first commercial [[antihistamines]].<ref name=nytobit/><ref name="nature_ball"/> In 1949 Djerassi became associate director of research at [[Syntex]] in [[Mexico City]] and remained there through 1951.<ref name=CHFOralHistory/> He has said that one factor influencing him to choose Syntex was that they had a [[DU spectrophotometer]].<ref name=Instrumentation>{{cite book|last1=Board on Physics and Astronomy, Division on Engineering and Physical Sciences|title=Instrumentation for a better tomorrow: proceedings of a symposium in honor of Arnold Beckman|date=2006|publisher=National Academies Press|location=Washington, D.C.|isbn=978-0-309-10116-5|url=https://books.google.com/books?id=9wlYap6UfE8C&pg=PA14|access-date=May 28, 2015}}</ref> He worked on a new synthesis of [[cortisone]] based on [[diosgenin]], a [[steroid]] [[sapogenin]] derived from a Mexican wild yam.<ref name=Syntex2005>{{cite journal|last1=Rosenkranz|first1=George|title=The Early Days of Syntex|journal=Chemical Heritage Magazine|date=2005|volume=23|issue=2|pages=8β13}}</ref> His team later synthesized [[norethisterone]] (norethindrone),<ref>{{Cite journal | last1 = Djerassi | first1 = C. | last2 = Miramontes | first2 = L. | last3 = Rosenkranz | first3 = G. | last4 = Sondheimer | first4 = F. | title = Steroids. LIV.1Synthesis of 19-Nov-17Ξ±-ethynyltestosterone and 19-Nor-17Ξ±-methyltestosterone2 | doi = 10.1021/ja01645a010 | journal = Journal of the American Chemical Society | volume = 76 | issue = 16 | pages = 4092β4094 | year = 1954 | bibcode = 1954JAChS..76.4092D }}</ref> the first highly active [[progestin]] analogue that was effective when taken by mouth. This became part of one of the first successful combined oral contraceptive pills, known colloquially as the birth-control pill, or simply, [[the Pill]]. From 1952 to 1959 he was professor of chemistry at [[Wayne State University]] in Detroit.<ref name=CHFOralHistory/> Djerassi participated in the invention in 1951, together with Mexican [[Luis E. Miramontes]] and Hungarian-Mexican [[George Rosenkranz]], of the [[progestin]] [[norethisterone]]βwhich, unlike [[progesterone]], remained effective when taken orally and was far stronger than the naturally occurring [[hormone]]. His preparation was first administered as an oral contraceptive to animals by [[Gregory Goodwin Pincus]] and [[Min Chueh Chang]] and to women by [[John Rock (American scientist)|John Rock]].<ref name=GaurdianObituary>{{cite news|title=Carl Djerassi obituary|last1=Hayman|first1=Suzie|url=https://www.theguardian.com/science/2015/feb/01/carl-djerassi|access-date=February 2, 2015|work=The Guardian|date=February 1, 2015}}</ref> In 1957, he became vice president of research at Syntex in Mexico City while on leave of absence from Wayne State. In 1960 Djerassi became a professor of chemistry at [[Stanford University]],<ref name=CHFOralHistory/> a position he held until 2002 <ref>{{cite news| url=https://www.bloomberg.com/news/articles/2015-01-31/carl-djerassi-chemist-behind-birth-control-pill-dies-at-91 | work=Bloomberg | first=Laurence | last=Arnold | title=Carl Djerassi, Chemist Behind Birth-Control Pill, Dies at 91 | date=January 31, 2015}}</ref> but only part-time as he never left industry.<ref name=zare /> From 1968 until 1972 he also served as president of Syntex Research at [[Palo Alto]].<ref name=CHFOralHistory/> The Syntex connection brought wealth to Djerassi. He bought a large tract of land in [[San Mateo County, California]], and started a cattle ranch called SMIP. (Initially an acronym for "Syntex Made It Possible", other variants have been suggested since.) He also assembled a large art collection. His collection of works by [[Paul Klee]] was considered to be one of the most significant to be privately held.<ref name=GuardianInterview/><ref name=ArtistsProgram>{{cite web|title=Djerassi Resident Artists Program|url=http://www.djerassi.org/programhistory.html|access-date=February 4, 2015|archive-url=https://web.archive.org/web/20150214174510/http://djerassi.org/programhistory.html|archive-date=February 14, 2015|url-status=dead}}</ref> He arranged for his Klee collections to be donated to the [[Albertina]] in Vienna and the [[San Francisco Museum of Modern Art]], effective on his death.<ref name=Tattler>{{cite web|title=Albertina's Modern Holdings Deepened by Transfer of Batliner Collection|url=http://arttattler.com/archivemodernmasterworks.html|website=Art Tattler International|access-date=February 4, 2015|url-status=dead|archive-url=https://web.archive.org/web/20150204193917/http://arttattler.com/archivemodernmasterworks.html|archive-date=February 4, 2015}}</ref> Throughout the 1960s and 1970s, Djerassi continued to do significant scientific work, as a professor in the department of chemistry at [[Stanford University]], and as an entrepreneur. He pioneered novel physical research techniques for [[mass spectrometry]] and [[optical rotatory dispersion]] and applied them to the areas of [[organic chemistry]] and the life sciences.<ref name=Reinhardt2015/> Focusing on the steroid hormones and alkaloids, he elucidated the structure of steroids, an area in which he published over 1,200 papers.<ref name=nytobit/> His scientific interests were wide-ranging, and his technological achievements include work in instrumentation, pharmaceuticals, insect control, the application of artificial intelligence in biomedical research, and the biology and chemistry of marine organisms.<ref name=Reinhardt2015/> In 1968, he started a new company, Zoecon,<ref name=CHFOralHistory/> which focused on environmentally soft methods of [[pest control]], using modified insect growth hormones to stop insects from metamorphosing from the larval stage to the [[pupa]]l and adult stages.<ref name=Roaches>{{cite book|last1=Wells|first1=Ken|title=Herd on the street: animal stories from the Wall Street journal|date=2003|publisher=Free Press|location=New York|isbn=978-0-7432-5420-5|pages=233β244|url=https://books.google.com/books?id=PHQywCUie1AC&pg=PA234}}</ref> Zoecon was eventually acquired by [[Occidental Petroleum]], which later sold it to [[Sandoz]], now [[Novartis]]. Part of Zoecon survives in [[Dallas]], Texas, making products to control [[flea]]s and other pests. In 1965 at Stanford University, nobel laureate [[Joshua Lederberg]], computer scientist [[Edward Feigenbaum]], and Djerassi devised the computer program [[Dendral|DENDRAL]] (dendritic algorithm) for the elucidation of the molecular structure of unknown organic compounds taken from known groups of such compounds, such as the alkaloids and the steroids.<ref name="NLM 2011">{{cite web|date=July 2011|title=The Joshua Lederberg Papers: Computers, Artificial Intelligence, and Expert Systems in Biomedical Research|work=Profiles in Science|location=Bethesda, Md.|publisher=[[United States National Library of Medicine|U.S. National Library of Medicine]]|url=http://profiles.nlm.nih.gov/ps/retrieve/Narrative/BB/p-nid/31|access-date=August 2, 2011}}</ref> This was a prototype for [[expert system]]s and one of the first uses of [[artificial intelligence]] in biomedical research.<ref name="NLM 2011"/> Djerassi was a member of the Board of Sponsors of the ''[[Bulletin of the Atomic Scientists]]''<ref>{{cite web|title=Board of Sponsors|work=[[Bulletin of the Atomic Scientists]]|url=http://thebulletin.org/content/about-us/board-of-sponsors|url-status=dead|archive-url=https://web.archive.org/web/20090218145005/http://thebulletin.org/content/about-us/board-of-sponsors|archive-date=February 18, 2009}}</ref> and was chairman of the [[Pharmanex]] Scientific Advisory Board.<ref>{{cite web|title=Carl Djerassi, Ph.D.| work=Pharmanews|publisher=[[Nu Skin Enterprises|Phamanex]]|url=http://www.pharmanex.com/corp/pharmanews/sab/carl_djerassi.shtml|access-date=December 17, 2006}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)